Insulins and analogues

Key figures

PRESCRIBERS
Main prescribers: Endocrinology-diabetology	42.95%
INSURED CONSUMERS
% of insured consumers	1.48%
Median age	67 years
Max/min ratio of the median age (by district)	1.11
Percentage of women	45.76%
Ratio Preferential scheme/General scheme	2.22
Coefficient of variation (2023)	11.92
Max/min ratio of % of insured consumers (by district)	1.50
CONSUMPTION
Annual consumption (DDD)	78,437,523
Consumption of DDD (per 100,000 insured persons)	680,851.43
% DDD issued outside the insurance (approximate)	1.15%
Average annual consumption per insured consumer (DDD)	460.74
% of insured consumers with > 3 times the average consumption	2,82%
Coefficient of variation 2013-2015	13.69
Coefficient of variation 2021-2023	15.71
Trend 2013-2023	0.37%
Trend 2013-2021	0.66%
Trend 2021-2023	-0.81%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance	86,440,617 €
Average annual expenditure per insured person	7.50 €
Average patient share per insured consumer	0.00%
Max/min ratio of expenditure per insured person (by disctrict)	1.75
% “Low-cost” medication	31.26%
Trend 2013-2023	-0.38%
Trend 2021-2023	-3.95%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on a yellow background, otherwise on a grey background.

Data

ATC codes selected for analysis

CODES (ATC-5)	LABELS
A10AB	INSULINS AND ANALOGUES FOR INJECTION, FAST-ACTING
A10AC	INSULINS AND ANALOGUES FOR INJECTION, INTERMEDIATE-ACTING
A10AD	INSULINS AND ANALOGUES FOR INJECTION, INTERMEDIATE-ACTING COMBINED WITH FAST-ACTING
A10AE	INSULINS AND ANALOGUES FOR INJECTION, LONG-ACTING